Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Fuel Tech Awarded Air Pollution Control Orders Totaling $2.6 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.6 Million


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and

E*TRADE Bolsters Corporate Services Capabilities Through Purchase of Pioneering Student Loan Benefit Provider Gradifi
E*TRADE Bolsters Corporate Services Capabilities Through Purchase of Pioneering Student Loan Benefit Provider Gradifi


E*TRADE Financial Corporate Services, Inc. today announced the addition of financial wellness capabilities through the purchase of student loan benefit and financial wellness provider Gradifi.

Cambium Networks Selects Sequans for Advanced LTE Equipment
Cambium Networks Selects Sequans for Advanced LTE Equipment


LTE chipmaker Sequans Communications (NYSE: SQNS) announced that Cambium Networks (NASDAQ: CMBM), a leading global provider of wireless networking solutions, has adopted Sequans’ LTE-Advanced

Ventas to Donate $9 Million To Support Elementary and Middle School Education in Philadelphia
Ventas to Donate $9 Million To Support Elementary and Middle School Education in Philadelphia


Ventas, Inc. (NYSE: VTR), a leading real estate investment trust, will donate nearly $9 million to provide major funding for the design, construction and development of a new K-8 public school

Franklin Covey Repurchases Shares in Knowledge Capital Wind-up
Franklin Covey Repurchases Shares in Knowledge Capital Wind-up


Franklin Covey Co (NYSE: FC) announced that it had repurchased $10 million of its common shares from Knowledge Capital Investment Group at a price of $35.14 per share. Knowledge Capital held about

Lantheus Enters into Strategic Collaboration with CarThera for Use of Microbubbles in Combination with SonoCloud® System for Treatment of Glioblastoma
Lantheus Enters into Strategic Collaboration with CarThera for Use of Microbubbles in Combination with SonoCloud® System for Treatment of Glioblastoma


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative

ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting
ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting


ArQule, Inc. (Nasdaq: ARQL) today announced final results from the phase 1 study for ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of both wild type and C481S-mutant

AgeX Therapeutics Issues Year-End Letter to Shareholders
AgeX Therapeutics Issues Year-End Letter to Shareholders


AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, issued a letter to shareholders from Michael D

NICE Wins Two ‘ASTORS’ Awards for Best Investigation and Best 911 Incident Recording and Analytics Solutions
NICE Wins Two ‘ASTORS’ Awards for Best Investigation and Best 911 Incident Recording and Analytics Solutions


NICE (Nasdaq: NICE) announced today that it has won two ‘ASTORS’ Awards for NICE Inform and NICE Investigate. Sponsored by American Security Today, the ‘ASTORS’ Awards recognize outstanding product

Undertone and TVadSync Join Forces to Unify Digital and TV Experiences, Creating an Unequalled, Cross-Platform Targeting Engine
Undertone and TVadSync Join Forces to Unify Digital and TV Experiences, Creating an Unequalled, Cross-Platform Targeting Engine


Perion Network Ltd. (NASDAQ:PERI) announced today that Undertone, the creator of cross-platform Synchronized Digital Branding for the world’s most prominent brands, and TVadSync, a leading TV data

Sangamo Announces Preliminary Results From the First Three Patients in a Phase 1/2 Study Evaluating ST-400 Ex Vivo Gene-edited Cell Therapy in Beta Thalassemia
Sangamo Announces Preliminary Results From the First Three Patients in a Phase 1/2 Study Evaluating ST-400 Ex Vivo Gene-edited Cell Therapy in Beta Thalassemia


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced preliminary results from the first three patients treated in the Phase 1/2 THALES study evaluating

Aurinia Announces Public Offering of Common Shares
Aurinia Announces Public Offering of Common Shares


Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today

The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191208005050/en/



The National Eye Hospital (CHNO) of the Quinze-Vingt

Verimatrix Completes Sale of its Silicon IP Business Unit to Rambus
Verimatrix Completes Sale of its Silicon IP Business Unit to Rambus


Regulatory News:



Verimatrix (Euronext Paris: VMX), formerly known as Inside Secure, a global provider of security and analytics solutions that protect devices, services and applications, today

Updated Clinical Data from Phase 2 SPiReL Study Evaluating DPX-Survivac as a Combination Therapy in r/r DLBCL Presented at 61st American Society of Hematology (ASH) Annual Meeting
Updated Clinical Data from Phase 2 SPiReL Study Evaluating DPX-Survivac as a Combination Therapy in r/r DLBCL Presented at 61st American Society of Hematology (ASH) Annual Meeting


IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that updated results from SPiReL, an ongoing Phase 2

Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment
Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE), today announced updated follow-up results from the Phase 1/2 Alta study evaluating

The Current Case For MLPs | Collecting Tolls On The Energy Express
The Current Case For MLPs | Collecting Tolls On The Energy Express

Published December 7th, 2019

This is a guest contribution from Real Investment Advice and Premium service RIA Pro. RIA Pro helps individual and professional investors grow capital and manage

Axcella Presents Data at ASH Annual Meeting
Axcella Presents Data at ASH Annual Meeting


Axcella Health Inc. (Nasdaq: AXLA), a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health

Eastmain Resources Announces Management Change
Eastmain Resources Announces Management Change


Eastmain Resources Inc. (TSX:ER) (the “Company” or “Eastmain”) announces the appointment of Blair Schultz as Interim President and Chief Executive Officer, effective immediately. Mr. Schultz has

Fifth Third Issues Statement on Temporary Network Outage
Fifth Third Issues Statement on Temporary Network Outage


Fifth Third Bank, National Association, today issued the following statement related to a temporary network outage this afternoon:



“Earlier today we experienced a temporary outage with our

Navidea Biopharmaceuticals Announces $1.9 Million Private Placement
Navidea Biopharmaceuticals Announces $1.9 Million Private Placement


Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today

PICO Holdings, Inc. Announces Sale of Long-Term Storage Credits in Arizona
PICO Holdings, Inc. Announces Sale of Long-Term Storage Credits in Arizona


PICO Holdings, Inc. (NASDAQ: PICO) announced today that the city of El Mirage in Arizona has approved the purchase from the Company’s wholly owned subsidiary, Vidler Water Company Inc., (“Vidler”)

Ventas Declares Fourth Quarter 2019 Dividend
Ventas Declares Fourth Quarter 2019 Dividend


Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) has declared a regular quarterly dividend of $0.7925 per share, payable in cash on January 13, 2020 to stockholders of record on January 2

Groupon to Participate in the Barclays Global Technology, Media and Telecommunications Conference
Groupon to Participate in the Barclays Global Technology, Media and Telecommunications Conference


Groupon, Inc. (NASDAQ: GRPN), a global leader in local commerce, today announced that Rich Williams, Chief Executive Officer, and Melissa Thomas, Interim Chief Financial Officer, will attend the

VICI Properties Inc. Completes Acquisition of Three Regional Gaming Properties and Enters Into Master Lease Agreement With Century Casinos, Inc.
VICI Properties Inc. Completes Acquisition of Three Regional Gaming Properties and Enters Into Master Lease Agreement With Century Casinos, Inc.


VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) an experiential real estate investment trust, today announced it has completed the previously announced transaction to acquire